Physician profile
Kamaljit Singh
NPI 1811283633
$1,044.39
in general payments reported to CMS, 2019-2025
22 companies · $122 in 2025
The $122 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $38.18 · 2020: $57.60 · 2021: $106 · 2022: $271 · 2023: $215 · 2024: $235 · 2025: $122.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $572.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $572.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cranial Technologies, INC | $158.60 | 2020-2024 | Doc Band |
| Cumberland Pharmaceuticals, INC. | $127.52 | 2021-2024 | Kristalose |
| Corium, LLC | $96.63 | 2022-2024 | Azstarys, Azstarys |
| Novo Nordisk INC | $92.69 | 2023-2024 | Wegovy |
| Alk-Abello, INC | $71.90 | 2023-2025 | Neffy, Odactra, Ragwitek |
| Tolmar, INC. | $61.74 | 2023 | |
| Tris Pharma INC | $56.99 | 2021-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $54.77 | 2021-2022 | |
| Sanofi-Aventis U.S. LLC | $51.95 | 2024-2025 | |
| Pfizer INC. | $34.33 | 2024-2025 | |
| Biohaven Pharmaceutical Holding Company LTD. | $30.68 | 2022 | |
| Merck Sharp & Dohme LLC | $27.58 | 2019-2023 | Vaxneuvance, Gardasil 9, Vaxelis |
| Mission Pharmacal Company | $25.75 | 2019 | |
| Cognoa, INC. | $21.80 | 2022 | |
| Impel Pharmaceuticals INC. | $18.74 | 2022 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Phadia US INC. | $18.65 | 2023 | Immunocap |
| Abbott Laboratories | $18.27 | 2022 | |
| Exact Sciences Corporation | $17.56 | 2025 | The Cologuard Plus Collection Kit |
| Hologic Sales and Service, LLC | $17.23 | 2025 | Aptima |
| Insulet Corporation | $13.91 | 2023 | Omnipod |
| Genentech USA, INC. | $13.80 | 2020 | |
| Ani Pharmaceuticals, INC. | $13.30 | 2024 | Purified Cortrophin Gel |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kamaljit Singh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.